Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
SIRO's Cash to Debt is ranked higher than
65% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.56 vs. SIRO: No Debt )
Ranked among companies with meaningful Cash to Debt only.
SIRO' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: 1.00 Max: No Debt
Current: No Debt
Equity to Asset 0.73
SIRO's Equity to Asset is ranked higher than
64% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. SIRO: 0.73 )
Ranked among companies with meaningful Equity to Asset only.
SIRO' s Equity to Asset Range Over the Past 10 Years
Min: -0.11  Med: 0.54 Max: 0.88
Current: 0.73
-0.11
0.88
Interest Coverage 53.51
SIRO's Interest Coverage is ranked lower than
99.99% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.90 vs. SIRO: 53.51 )
Ranked among companies with meaningful Interest Coverage only.
SIRO' s Interest Coverage Range Over the Past 10 Years
Min: 1.68  Med: 40.92 Max: 9999.99
Current: 53.51
1.68
9999.99
F-Score: 6
Z-Score: 9.20
M-Score: -2.50
WACC vs ROIC
9.35%
23.39%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 22.36
SIRO's Operating margin (%) is ranked higher than
87% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.71 vs. SIRO: 22.36 )
Ranked among companies with meaningful Operating margin (%) only.
SIRO' s Operating margin (%) Range Over the Past 10 Years
Min: 8.16  Med: 18.29 Max: 35.64
Current: 22.36
8.16
35.64
Net-margin (%) 16.33
SIRO's Net-margin (%) is ranked higher than
87% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. SIRO: 16.33 )
Ranked among companies with meaningful Net-margin (%) only.
SIRO' s Net-margin (%) Range Over the Past 10 Years
Min: 3.89  Med: 13.33 Max: 22.45
Current: 16.33
3.89
22.45
ROE (%) 14.82
SIRO's ROE (%) is ranked higher than
78% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. SIRO: 14.82 )
Ranked among companies with meaningful ROE (%) only.
SIRO' s ROE (%) Range Over the Past 10 Years
Min: 4.64  Med: 13.98 Max: 26.05
Current: 14.82
4.64
26.05
ROA (%) 10.50
SIRO's ROA (%) is ranked higher than
82% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. SIRO: 10.50 )
Ranked among companies with meaningful ROA (%) only.
SIRO' s ROA (%) Range Over the Past 10 Years
Min: 1.78  Med: 7.83 Max: 22.72
Current: 10.5
1.78
22.72
ROC (Joel Greenblatt) (%) 85.40
SIRO's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.36 vs. SIRO: 85.40 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SIRO' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 45.65  Med: 86.54 Max: 275.82
Current: 85.4
45.65
275.82
Revenue Growth (3Y)(%) 6.10
SIRO's Revenue Growth (3Y)(%) is ranked higher than
57% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. SIRO: 6.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SIRO' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -23.4  Med: 9.30 Max: 71.9
Current: 6.1
-23.4
71.9
EBITDA Growth (3Y)(%) 7.00
SIRO's EBITDA Growth (3Y)(%) is ranked higher than
52% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.60 vs. SIRO: 7.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SIRO' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -30.1  Med: 12.40 Max: 84
Current: 7
-30.1
84
EPS Growth (3Y)(%) 11.90
SIRO's EPS Growth (3Y)(%) is ranked higher than
63% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. SIRO: 11.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SIRO' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -8.7  Med: 13.70 Max: 58.7
Current: 11.9
-8.7
58.7
» SIRO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

SIRO Guru Trades in Q1 2015

Columbia Wanger 575,231 sh (unchged)
Ron Baron 67,403 sh (unchged)
Ruane Cunniff 2,827,202 sh (unchged)
Dodge & Cox Sold Out
Chuck Royce Sold Out
Joel Greenblatt Sold Out
Jeremy Grantham 64,800 sh (-3.86%)
» More
Q2 2015

SIRO Guru Trades in Q2 2015

Joel Greenblatt 8,577 sh (New)
Columbia Wanger 611,440 sh (+6.29%)
Ruane Cunniff 2,841,520 sh (+0.51%)
Ron Baron 63,252 sh (-6.16%)
Jeremy Grantham 48,900 sh (-24.54%)
» More
Q3 2015

SIRO Guru Trades in Q3 2015

Paul Tudor Jones 3,600 sh (New)
Ron Baron Sold Out
Joel Greenblatt Sold Out
Ruane Cunniff 2,826,405 sh (-0.53%)
Columbia Wanger 585,014 sh (-4.32%)
Jeremy Grantham 45,975 sh (-5.98%)
» More
Q4 2015

SIRO Guru Trades in Q4 2015

Jim Simons 241,600 sh (New)
Jeremy Grantham 42,775 sh (-6.96%)
Columbia Wanger 454,184 sh (-22.36%)
» More
» Details

Insider Trades

Latest Guru Trades with SIRO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 29.14
SIRO's P/E(ttm) is ranked higher than
50% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.14 vs. SIRO: 29.14 )
Ranked among companies with meaningful P/E(ttm) only.
SIRO' s P/E(ttm) Range Over the Past 10 Years
Min: 15.41  Med: 27.27 Max: 782.2
Current: 29.14
15.41
782.2
Forward P/E 22.12
SIRO's Forward P/E is ranked lower than
62% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.84 vs. SIRO: 22.12 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 29.14
SIRO's PE(NRI) is ranked higher than
50% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.14 vs. SIRO: 29.14 )
Ranked among companies with meaningful PE(NRI) only.
SIRO' s PE(NRI) Range Over the Past 10 Years
Min: 15.51  Med: 27.19 Max: 782.2
Current: 29.14
15.51
782.2
P/B 4.09
SIRO's P/B is ranked lower than
77% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.27 vs. SIRO: 4.09 )
Ranked among companies with meaningful P/B only.
SIRO' s P/B Range Over the Past 10 Years
Min: 0.84  Med: 3.24 Max: 11.6
Current: 4.09
0.84
11.6
P/S 4.76
SIRO's P/S is ranked lower than
96% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.86 vs. SIRO: 4.76 )
Ranked among companies with meaningful P/S only.
SIRO' s P/S Range Over the Past 10 Years
Min: 0.74  Med: 3.40 Max: 7.43
Current: 4.76
0.74
7.43
PFCF 29.01
SIRO's PFCF is ranked lower than
51% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.49 vs. SIRO: 29.01 )
Ranked among companies with meaningful PFCF only.
SIRO' s PFCF Range Over the Past 10 Years
Min: 9.65  Med: 22.34 Max: 99.96
Current: 29.01
9.65
99.96
POCF 22.86
SIRO's POCF is ranked lower than
64% of the 205 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.81 vs. SIRO: 22.86 )
Ranked among companies with meaningful POCF only.
SIRO' s POCF Range Over the Past 10 Years
Min: 5.89  Med: 16.19 Max: 115.33
Current: 22.86
5.89
115.33
EV-to-EBIT 20.22
SIRO's EV-to-EBIT is ranked lower than
51% of the 208 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.49 vs. SIRO: 20.22 )
Ranked among companies with meaningful EV-to-EBIT only.
SIRO' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.5  Med: 19.45 Max: 97.1
Current: 20.22
10.5
97.1
EV-to-EBITDA 15.97
SIRO's EV-to-EBITDA is ranked lower than
53% of the 227 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.89 vs. SIRO: 15.97 )
Ranked among companies with meaningful EV-to-EBITDA only.
SIRO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 13.00 Max: 57.5
Current: 15.97
5.5
57.5
PEG 3.49
SIRO's PEG is ranked lower than
57% of the 63 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.97 vs. SIRO: 3.49 )
Ranked among companies with meaningful PEG only.
SIRO' s PEG Range Over the Past 10 Years
Min: 0.37  Med: 1.85 Max: 18.98
Current: 3.49
0.37
18.98
Shiller P/E 51.49
SIRO's Shiller P/E is ranked lower than
76% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 37.26 vs. SIRO: 51.49 )
Ranked among companies with meaningful Shiller P/E only.
SIRO' s Shiller P/E Range Over the Past 10 Years
Min: 26.39  Med: 49.60 Max: 88.94
Current: 51.49
26.39
88.94
Current Ratio 2.89
SIRO's Current Ratio is ranked higher than
58% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. SIRO: 2.89 )
Ranked among companies with meaningful Current Ratio only.
SIRO' s Current Ratio Range Over the Past 10 Years
Min: 0.75  Med: 2.20 Max: 8.27
Current: 2.89
0.75
8.27
Quick Ratio 2.45
SIRO's Quick Ratio is ranked higher than
64% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. SIRO: 2.45 )
Ranked among companies with meaningful Quick Ratio only.
SIRO' s Quick Ratio Range Over the Past 10 Years
Min: 0.17  Med: 1.73 Max: 7.7
Current: 2.45
0.17
7.7
Days Inventory 91.89
SIRO's Days Inventory is ranked higher than
72% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.52 vs. SIRO: 91.89 )
Ranked among companies with meaningful Days Inventory only.
SIRO' s Days Inventory Range Over the Past 10 Years
Min: 41.2  Med: 71.95 Max: 89.92
Current: 91.89
41.2
89.92
Days Sales Outstanding 60.05
SIRO's Days Sales Outstanding is ranked higher than
73% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 64.05 vs. SIRO: 60.05 )
Ranked among companies with meaningful Days Sales Outstanding only.
SIRO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.03  Med: 46.59 Max: 50.29
Current: 60.05
36.03
50.29
Days Payable 34.99
SIRO's Days Payable is ranked lower than
60% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.85 vs. SIRO: 34.99 )
Ranked among companies with meaningful Days Payable only.
SIRO' s Days Payable Range Over the Past 10 Years
Min: 35.31  Med: 41.84 Max: 52.38
Current: 34.99
35.31
52.38

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 15.25
SIRO's Price/Net Current Asset Value is ranked lower than
77% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.21 vs. SIRO: 15.25 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
SIRO' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 4  Med: 8.39 Max: 3510
Current: 15.25
4
3510
Price/Tangible Book 9.58
SIRO's Price/Tangible Book is ranked lower than
84% of the 233 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.21 vs. SIRO: 9.58 )
Ranked among companies with meaningful Price/Tangible Book only.
SIRO' s Price/Tangible Book Range Over the Past 10 Years
Min: 1  Med: 9.10 Max: 198.23
Current: 9.58
1
198.23
Price/Projected FCF 1.89
SIRO's Price/Projected FCF is ranked lower than
59% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. SIRO: 1.89 )
Ranked among companies with meaningful Price/Projected FCF only.
SIRO' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.53  Med: 1.55 Max: 12.81
Current: 1.89
0.53
12.81
Price/DCF (Earnings Based) 1.07
SIRO's Price/DCF (Earnings Based) is ranked higher than
85% of the 41 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.95 vs. SIRO: 1.07 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.40
SIRO's Price/Median PS Value is ranked lower than
75% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.02 vs. SIRO: 1.40 )
Ranked among companies with meaningful Price/Median PS Value only.
SIRO' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.04  Med: 0.89 Max: 2.19
Current: 1.4
0.04
2.19
Price/Peter Lynch Fair Value 3.54
SIRO's Price/Peter Lynch Fair Value is ranked lower than
84% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. SIRO: 3.54 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
SIRO' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.48  Med: 1.94 Max: 30.26
Current: 3.54
0.48
30.26
Price/Graham Number 3.53
SIRO's Price/Graham Number is ranked lower than
69% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.39 vs. SIRO: 3.53 )
Ranked among companies with meaningful Price/Graham Number only.
SIRO' s Price/Graham Number Range Over the Past 10 Years
Min: 0.26  Med: 3.33 Max: 14.77
Current: 3.53
0.26
14.77
Earnings Yield (Greenblatt) (%) 4.99
SIRO's Earnings Yield (Greenblatt) (%) is ranked higher than
66% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. SIRO: 4.99 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SIRO' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1  Med: 5.10 Max: 9.5
Current: 4.99
1
9.5
Forward Rate of Return (Yacktman) (%) 10.75
SIRO's Forward Rate of Return (Yacktman) (%) is ranked higher than
54% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.84 vs. SIRO: 10.75 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SIRO' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 2  Med: 21.80 Max: 56
Current: 10.75
2
56

More Statistics

Revenue(Mil) $1173
EPS $ 3.39
Beta1.02
Short Percentage of Float3.13%
52-Week Range $86.29 - 113.58
Shares Outstanding(Mil)56.03

Analyst Estimate

Sep16
Revenue(Mil)
EPS($) 4.47
EPS without NRI($) 4.47

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:RXT.Germany,
Sirona Dental Systems Inc was founded in 1997 and completed an initial public offering of its common stock on July 1, 1997. The Company is a manufacturer of high-quality, dental equipment, and is engaged in developing, manufacturing and marketing solutions for dentists around the world. The Company provides products in each of its four product segments: Dental CAD/CAM Systems; Imaging Systems; Treatment Centers; and Instruments. The Company markets its products globally to dental practices, clinics and laboratories through an international network of distributors. The dental market encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Recent technological advancements in the dental equipment industry include 3D radiography, digital radiography, CAD/CAM technology, intra oral cameras and periodontal instruments. The market it serves comprises the whole working environment of a dentist or dental technician, including the dentist's chair, lights, imaging systems and dental CAD/CAM systems, instruments, as well as practice furniture and other dental or lab-based systems. Dental CAD/CAM Systems address the market for dental restorations, which includes several types of restorations, such as inlays, onlays, veneers, crowns, bridges, copings and bridge frameworks made from ceramic, metal or composite blocks. The Company has developed a range of imaging systems for 2D and 3D, panoramic and intra-oral applications that allow the dentist to accommodate the patient in a more efficient manner. Treatment Centers comprise products from basic dentist chairs to sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, as well as specialist centers used in preventative treatment and for training purposes. In July 2008, the Company launched its new TENEO Treatment Center, which combines technology with a timeless design that provides both patient and dentist with the ultimate in convenience and comfort. The Company offers a range of instruments, including handheld and power-operated handpieces for cavity preparation, endodontics, periodontology and prophylaxis. The instruments are supplemented by multi-function tips, supply and suction hoses, as well as care and hygiene systems for instrument preparation. Its product information is actively made available to business publications, dentists, journals, professional organizations and dental schools, and its website. Sirona distributes its products globally to dental practices, clinics and laboratories through an international network of more than 480 distributors. The Companys registered trademarks include, Sirona, CEREC, Orthophos, Heliodent, inLab, CDR, and Schick. It competes with different companies which include international companies as well as smaller companies that compete regionally or on a narrower product line. The Company is subject to government regulations applicable to all businesses
» More Articles for SIRO

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BWEN, DDMG, ZHNE, ENZ, SIRO Nov 28 2011 
Weekly CEO Buys Highlight: KMI, VGR, SIRO, PNK, MASI Nov 27 2011 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Nov 18 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Feb 23 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Dec 17 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Dec 04 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Jul 31 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) May 06 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Feb 05 2009 

More From Other Websites
SIRONA DENTAL SYSTEMS, INC. Financials Feb 11 2016
Sirona Dental Systems, Inc. Earnings Analysis: Q1, 2016 By the Numbers Feb 10 2016
Sirona Dental tops Street 1Q forecasts Feb 08 2016
Sirona Dental tops Street 1Q forecasts Feb 08 2016
SIRONA DENTAL SYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 08 2016
SIRONA DENTAL SYSTEMS, INC. Files SEC form 10-Q, Quarterly Report Feb 08 2016
Sirona Reports Fiscal 2016 First Quarter Results Feb 08 2016
Sirona Dental Systems, Inc. breached its 50 day moving average in a Bullish Manner : February 2,... Feb 02 2016
SIRONA DENTAL SYSTEMS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Jan 11 2016
DENTSPLY AND SIRONA SHAREHOLDERS APPROVE MERGER Jan 11 2016
DENTSPLY AND SIRONA SHAREHOLDERS APPROVE MERGER Jan 11 2016
Sirona Dental Systems, Inc. – Value Analysis (NASDAQ:SIRO) : January 5, 2016 Jan 05 2016
Sirona Dental Systems, Inc. breached its 50 day moving average in a Bearish Manner : January 5, 2016 Jan 05 2016
Sirona Dental Systems, Inc. breached its 50 day moving average in a Bearish Manner : December 15,... Dec 15 2015
SIRONA DENTAL SYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Dec 11 2015
DENTSPLY International at 52-Week High on Sirona Buyout Dec 04 2015
Market Gives Up Previous Day’s Gains and IHI Falls 0.55% Dec 03 2015
Hedge Fund Confidence in Sirona Dental Systems, Inc. (SIRO) is Soaring Dec 02 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK